207433 Health Care Inequalities in World Cities

Sunday, November 8, 2009

Michael Kelley Gusmano, PhD , Health Policy and Management, State University of New York at Downstate Medical Center, Brooklyn, NY
Mortality amenable to health care is a summary measure of the extent to which access to disease prevention, primary care, as well as specialty services, contribute to the reduction of premature mortality. Hospital discharges for so-called “avoidable hospitalizations” reflect the extent to which there are access barriers to timely and effective primary care services and disease management services. These indicators capture important dimension of inequalities in access to timely and effective disease prevention, primary care and/or specialty services, but they have never been used together, in a systematic way, to measure health system inequities. I use these indicators as a tool for assessing the health care systems in New York, London, Hong Kong and Paris. This approach provides a useful comparative analysis for understanding health care and health inequalities among and within these world cities and provokes important questions about how these cities can learn from one another, particularly with respect to the descriptive information on the experience of city's programs and policies on inter-sectoral action to improve population health.

Learning Objectives:
We will compare access to health care among 4 world cities using two indicators: amenable mortality and avoidable hospital conditions.

Keywords: Access to Health Care, Urban Health Services Barriers

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I have a Ph.D. in Political Science and a Master's degree in public policy. I was on the faculty of the Mailman School of Public Health, Columbia University for four years and have been a member of the faculty in the Department of Health Policy and Management at SUNY Downstate since July 2008.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.